Cover Image
市場調查報告書

腸疾病檢驗的全球市場:2016∼2020年

Global Enteric Disease Testing Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 295850
出版日期 內容資訊 英文 65 Pages
訂單完成後即時交付
價格
Back to Top
腸疾病檢驗的全球市場:2016∼2020年 Global Enteric Disease Testing Market 2016-2020
出版日期: 2016年07月20日 內容資訊: 英文 65 Pages
簡介

腸疾病是由於細菌和病毒引起的感染疾病,有胃痛、嘔吐、腹瀉、噁心、食慾不振、發熱等症狀。腸疾病檢驗,採用即時檢測、培養檢驗、酵素免疫化驗檢驗等。全球腸疾病檢驗市場,預計2016∼2020年以8.9%的年複合成長率擴大。

本報告提供全球腸疾病檢驗市場相關調查,市場成長預測,各地區趨勢,市場趨勢與課題,主要供應商的競爭趨勢等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 償付方案:概要

第6章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 臨床診斷檢驗的種類

  • 免疫檢測檢驗
  • 分子診斷檢驗

第8章 腸疾病檢驗的全球市場:各疾病市場分類

  • 細菌
  • 病毒

第9章 腸疾病檢驗的全球市場:各地區分類

  • 各地區分類
  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第10章 腸疾病檢驗的全球市場:促進要素

  • 腸疾病的高發病率
  • 分子診斷檢驗的引進擴大
  • 新檢驗平台的取得

第11章 促進要素的影響

第12章 腸疾病檢驗的全球市場:課題

  • 嚴厲的法律制度
  • 發展中國家的認識不足
  • 熟練技術人員的不足

第13章 促進要素與課題的影響

第14章 腸疾病檢驗的全球市場:趨勢

第15章 供應商環境

  • 競爭模式
  • 主要供應商分析
  • 其他值得注意的供應商

第16章 附錄

第17章 關於Technavio

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR8514

About Enteric Diseases

Enteric diseases are infections caused by ingested bacteria and viruses. Direct contact with contaminated feces or vomit is the secondary mode of contracting enteric ailments. Symptoms of enteric diseases include stomach pain, vomiting, diarrhea, nausea, weight loss, anorexia, and fever. Enteric diseases may lead to stunted growth, malnutrition, and impaired cognitive development. Enteric disease testing is performed on individuals using rapid tests, culture tests, enzyme immunoassay tests, and immunoassay tests.

Technavio's analysts forecast the global enteric disease testing market to grow at a CAGR of 8.9% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global enteric disease testing market for 2016-2020. To calculate the market size, Technavio uses revenue generated from the sales of enteric disease testing products for Bacterial enterics (Clostridium difficile, Campylobacter, enterohemorrhagic Escherichia coli [EHEC], and Helicobacter pylori) and Viral enterics (Norovirus and Rotavirus)

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Enteric Disease Testing Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Alere
  • bioMerieux
  • Cepheid
  • DiaSorin

Other Prominent Vendors

  • BD
  • Biomerica
  • Coris BioConcept
  • Meridian Bioscience
  • Mobidiag
  • Quidel
  • Quest Diagnostics
  • R-Biopharm
  • Trinity Biotech
  • Thermo Fisher Scientific

Market driver

  • Increase in adoption of molecular diagnostic testing
  • For a full, detailed list, view our report

Market challenge

  • Lack of awareness in underdeveloped countries
  • For a full, detailed list, view our report

Market trend

  • Shift from singleplex to multiplex testing
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Reimbursement scenario: An overview

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Types of clinical diagnostic testing

  • Immunoassay testing
  • Molecular diagnostic testing

PART 08: Market segmentation by disease type

  • Bacterial enterics
  • Viral enterics

PART 09: Geographical segmentation

  • Geographical segmentation of global enteric disease testing market 2015-2020
  • Enteric disease testing market in Americas
  • Enteric disease testing market in EMEA
  • Enteric disease testing market in APAC

PART 10: Market drivers

  • High incidence of enteric diseases
  • Increase in adoption of molecular diagnostic testing
  • Availability of novel enteric testing platforms

PART 11: Impact of drivers

PART 12: Market challenges

  • Stringent regulatory environment
  • Lack of awareness in underdeveloped countries
  • Shortage of skilled technicians

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Development of novel NAAT for enteric disease testing
  • Shift from singleplex to multiplex testing

PART 15: Vendor landscape

  • Competitive scenario
  • Key vendor analysis
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Reimbursement perspectives of healthcare entities
  • Exhibit 03: Global enteric disease testing market
  • Exhibit 04: Global enteric disease testing market 2015-2020 ($ millions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Segmentation of global enteric disease testing market by microorganism 2015
  • Exhibit 07: Segmentation of global enteric disease testing market by geography 2015
  • Exhibit 08: Segmentation of global enteric disease testing market by geography 2020
  • Exhibit 09: Segmentation of global enteric disease testing market by geography 2015-2020
  • Exhibit 10: Enteric disease testing market in Americas 2015-2020 ($ millions)
  • Exhibit 11: Enteric disease testing market in EMEA 2015-2020 ($ millions)
  • Exhibit 12: Enteric disease testing market in APAC 2015-2020 ($ millions)
  • Exhibit 13: Impact of drivers
  • Exhibit 14: Impact of drivers and challenges
  • Exhibit 15: Alere: Key takeaways
  • Exhibit 16: bioMerieux: Key takeaways
  • Exhibit 17: Cepheid: Key takeaways
  • Exhibit 18: DiaSorin: Key takeaways
Back to Top